Market Research Hub (MRH) has actively included a new research study titled “Idiopathic Pulmonary Fibrosis (IPF)-Market Insights, Epidemiology and Market” Forecast-2028 to its wide online repository. The concerned market is discoursed based on a variety of market influential factors such as drivers, opportunities and restraints. This study ... Read more

Idiopathic pulmonary fibrosis is a progressive disease characterized by scarring (fibrosis) of the lungs. The IPF products on the market include drugs namely Ofev, Esbriet and more. These drugs are used to treat IPF by slowing down disease progression and improving lung functions.

The global Idiopathic Pulmonary Fibrosis Market is estimated to be valued at US$ 4188.86 Mn in 2023 and is expected to exhibit a CAGR of 8.7% over the forecast period 2023-2030, as highlighted in a ... Read more